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InhalationLinalool oxide is a monoterpene that is found in some species of aromatic plants. The effects of the inhalation
of linalool oxide (0.65%, 1.25%, 2.5% and 5.0% w/w) in the elevated plus-maze and light/dark box tests as an-
imal models of anxiety were investigated in adult male mice and compared with the effects of the reference
anxiolytic diazepam (0.5 and 2.0 mg/kg), administered intraperitoneally. Additionally, the effects of inhaled
linalool oxide were investigated in the rotarod test. Linalool oxide signiﬁcantly increased the number of visits
to the open arms of the elevated plus-maze and the amount of time spent there as well as the total number of
entries. In the light/dark box test, inhalation of linalool oxide led to an increase in the time spent by the mice
in the brightly-lit chamber and in the number of times the animal crossed from one compartment to another.
Performance on the rotarod was unaffected. Thus, inhaled linalool oxide was found to have anxiolytic prop-
erties in both animal models, without causing any motor deﬁcit. These results suggest that inhalation of
linalool oxide may be a useful means of counteracting anxiety.raíba, Laboratório de Tecnologia
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Anxiety disorders are common in the general population and basic
pharmacological treatment of these disorders incurs signiﬁcant costs,
thus constituting an important public health problem in developed
countries (Almeida et al., 2004; Bradley et al., 2007b). Furthermore,
the treatment of anxiety with the anxiolytic drugs currently on the
market today involves problems such as adverse and undesirable
effects. In an attempt to resolve these issues, interest has increased in
alternative therapies such as aromatherapy,which represents a possible
alternative to standard pharmacological treatment and has been used
for several conditions such as chronic pain, depression and anxiety
(Bradley et al., 2007b; Abuhamdah and Chazot, 2008).
Essential oils (EOs) are concentrated volatile compounds formed
as secondary metabolites in aromatic plants and characterized by a
strong odor (Bakkali et al., 2008; Silva et al., 2009). They have been
widely used in folk medicine and aromatherapy (Umezu et al.,
2002; Almeida et al., 2004). Studies have shown that certain EOsdecrease anxiety-related behavior in humans and animals (Bowers,
2006; Bradley et al., 2007b). Their biological effects may be the result
of the synergistic effect of all the molecules together or only of the
principal molecules present in larger concentrations in these oils
(Bakkali et al., 2008).
Linalool is a monoterpene frequently found as a major component
of EOs obtained from various species of well known aromatic plants
such as Lavandula angustifolia Mill., Melissa ofﬁcinalis L., Rosmarinus
ofﬁcinalis L. and Cymbopogon citratus DC (Elisabetsky et al., 1995;
Batista et al., 2008; Linck et al., 2009). It is widely used in themanufac-
ture of fragrances for shampoos, soaps and detergents (Mitić-Ćulaﬁć
et al., 2009).
Recent studies have shown that, when inhaled, linalool is clearly
sedative, inducing hypothermia, reducing ambulation and increasing
pentobarbital-induced sleep time in mice (Linck et al., 2009). In addi-
tion, its anxiolytic proﬁle has been demonstrated in the light/dark box
test and in social interaction and aggressive behavior tests (Linck
et al., 2010).
Linalool oxide is another substance that can also be found in some
herbal EOs, albeit as a minority component. It is a monocyclic alcohol
that can be formed from linalool by natural oxidation or may be pro-
duced by synthetic processes such as biotransformation of linalool
using the fungus Aspergillus niger. (Demyttenaere and Willemen,
1998; Hilmer and Gatﬁeld, 2004; Santos et al., 2008).
The objective of this study was to evaluate the possible anxiolytic
effects of inhaled linalool oxide in mice by using the elevated plus-
Fig. 1. Effect of linalool oxide on the number of open entries in EPM test. Evaluation of
different concentrations of linalool oxide by inhalation route (INH) and diazepam ad-
ministered intraperitoneally (i.p.) in male mice. Data are expressed as mean±SEM.
N=8. * pb0.05, ** pb0.01 compared with controls; ANOVA/Bonferroni multiple com-
parisons test.
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to investigate the presence of a nonspeciﬁc muscle relaxant effect of
this substance by using the rotarod test.
2. Materials and methods
2.1. Animals
Male Swiss (Musmusculus) albinomice (25–35 g) from the Professor
Dr. Thomas George animal laboratory at the Laboratory of Pharmaceutical
Technology, Federal University of Paraíba were used in these experi-
ments. Animalswere kept in polypropylene boxes coveredwith sawdust
and maintained at controlled temperature (21±1 °C), with a 12-hour
light/dark cycle (lights on at 6 a.m.). Food (Purina® pellets) and water
were given ad libitum until 1 h prior to the experimental procedures.
All experiments were performed between 12:00 p.m. and 5:00 p.m.
Experimental protocols and procedures were approved by the Animal
Experimentation Ethics Committee (CEPA/LTF) and are in accordance
with EC Directive 86/609/EEC.
2.2. Drugs and treatments
Linalool oxide (Sigma-Aldrich, Brazil) was diluted with polyox-
yethylene sorbitan monooleate (Tween 80 0.2% v/v in distilled
water, VETEC, Brazil) to prepare linalool oxide emulsions (0.65%,
1.25%, 2.5% and 5.0%) minutes prior to the experiments. Diazepam
(Merck, Brazil) was dissolved in saline solution and used as a positive
control (0.5 mg/kg or 2 mg/kg). It was administered intraperitoneally
(i.p.) at a volume of 0.1 ml/10 g of bodyweight. Negative control groups
consisted of inhaled 0.2% Tween or intraperitoneal saline solution.
2.3. Inhalation apparatus
The inhalation apparatus consisted of an acrylic box measuring
36×30×29 cm. The ﬂoor consisted of a stainless steel grid onto
which the animals were placed individually. There were four holes
(each measuring 2 cm in diameter) on the front and back walls into
which drug-embedded cotton wool was placed, alternating between
2.5 ml of saline solution and 2.5 ml of linalool oxide emulsion. Each
animal was individually evaluated in the test shortly after 7 min of
exposure to the inhalation chamber. Each animal was exposed only
once, and after four animals had been exposed, the cotton wool con-
taining the linalool oxide was replaced to ensure that the concentra-
tion of the drug was maintained.
2.4. Elevated plus-maze test
The elevated plus-maze (EPM) test was ﬁrst evaluated for rats
(Pellow et al., 1985) and later adapted formice (Lister, 1987). The open-
ness of the apparatus combined with its elevation serves to generate
behavioral changes predominantly associated with anxiety (Schmitt
and Hiemke, 1998). It relies on the natural anxiety-related behavior
of rodents to remain in shadows, close to walls and to avoid heights
(Bradley et al., 2007a). The apparatus was made of gray acrylic material
(Insight®) and consisted of two open arms (30×5×0.25 cm) and two
enclosed arms (30×5×15 cm) radiating from a central platform
(5×5 cm) to form a plus sign. The apparatus was elevated to a height
of 38.5 cmand placed inside a sound-attenuated room. At the beginning
of the trial, an animal was placed on the central platform of the maze,
facing an open arm. The number of entries and the time spent in the
open arms, as well as the number of crossings between compartments,
were counted during a 5-minute test period. Entry into an armwas con-
sidered valid only when all four paws of the animal were inside that
arm (Biala and Kruk, 2008).2.5. Light/dark box test
This test is based on the innate aversion of rodents to brightly lit
areas and on their spontaneous exploratory behavior in response to
a novel environment and to light (Pultrini et al., 2006). The apparatus
consisted of an acrylic box 28 cm wide, 14 cm high and 13.4 cm long,
divided into two separate compartments, occupying two-thirds and
one-third of the total volume, respectively. The larger chamber was
white and directly lit by a 60-watt light bulb,while the smaller chamber
was entirely black and enclosed under a dark cover. The compartments
were connected by an open door located at ﬂoor level in the center of
the box. At the beginning of the test, the mice were placed individually
at the center of the brightly lit chamber, facing the opening, and were
allowed to explore the entire apparatus for 5 min. During this experi-
mental session, the time spent in the well-lit compartment and the
number of transitions between compartments was registered. A com-
partment entry was considered valid when the animal's four paws
were inside that chamber.
2.6. Rotarod test
This procedure was ﬁrst described by Dunham andMiya, 1957 and
is suitable for detecting motor impairment due to pharmacological
agents such as skeletal muscle relaxants or central nervous system
depressants (Pultrini et al., 2006). The rotarod treadmill (Ugo Basile,
Model 7750, Italy) consisted of a bar with a diameter of 2.5 cm, sub-
divided into four compartments by disks of 25 cm in diameter rotating
at 7 revolutions per minute (rpm). Mice were submitted to three train-
ing sessions 24 h prior to testing and those lasting b90 s were rejected.
Motor performance was evaluated immediately prior to treatment
(basal) and at 30, 60 and 120 min after treatment.
2.7. Statistical analysis
The data obtainedwere evaluated using ANOVA followed by Bonfer-
ronimultiple comparisons test. Data were analyzed using the GraphPad
Prism software (version 5.0) and experimental groups were compared
with the vehicle group. P-valuesb0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Elevated plus-maze test
Fig. 1 shows that both linalool oxide inhalation (0.65%, 2.5% and
5.0% w/w) and intraperitoneal diazepam resulted in an increase in
the number of open entries compared to the respective control
groups (pb0.05 and pb0.01, respectively). As illustrated in Fig. 2,
Fig. 4. Effect of linalool oxide on the time (s) spent in light compartment in light–dark
box test. Evaluation of different concentrations of inhaled linalool oxide and diazepam
i.p. in male mice. Data are expressed as mean±SEM. N=8. * pb0.05, ** pb0.01,
*** pb0.001 compared with controls; ANOVA/Bonferroni multiple comparisons test.
Fig. 2. Effect of linalool oxide on the open duration (s) in EPM test. Evaluation of different
concentrations of inhaled linalool oxide anddiazepam i.p. inmalemice.Data are expressed
asmean±SEM. N=8. * pb0.05, ** pb0.01, *** pb0.001 comparedwith controls; ANOVA/
Bonferroni multiple comparisons test.
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the concentrations of linalool oxide and diazepam (pb0.05, pb0.01 and
pb0.001, respectively). The effects of linalool oxide inhalation (0.65%,
2.5% and 5.0%w/w) and intraperitoneal diazepam resulted in signiﬁcant
increases in the total number of entries into the arms (pb0.05, pb0.01
and pb0.001, respectively) (Fig. 3).
3.2. Light/dark box test
The results of the light/dark box test are shown in Figs. 4 and 5.
As shown in Fig. 4, all the linalool oxide and diazepam groups spent
signiﬁcantly more time in the brightly lit chamber compared to the
respective control groups (pb0.05, pb0.01 and pb0.001). In addition,
there was a signiﬁcant increase in the number of crossings between
the compartments as a consequence of the effect of 0.65%, 2.5% and
5.0% linalool oxide and diazepam compared to controls (pb0.05,
pb0.01 and pb0.001) (Fig. 5).
3.3. Rotarod test
Previous treatment with linalool oxide failed to modify motor per-
formance on the rotarod, unlike the signiﬁcant effect observed only
30 min following treatment with diazepam used as positive control
(Fig. 6).
4. Discussion
In the modern world, anxiety disorders have become common ail-
ments and are usually associated with other psychiatric disorders
(Linck et al., 2010). Despite the availability of treatment with the
arsenal of anxiolytic drugs currently available on the market, manyFig. 3. Effect of linalool oxide on the total arms entries in EPM test. Evaluation of different
concentrations of inhaled linalool oxide anddiazepam i.p. inmalemice.Data are expressed
asmean±SEM. N=8. * pb0.05, ** pb0.01, *** pb0.001 comparedwith controls; ANOVA/
Bonferroni multiple comparisons test.of these pharmaceutical options, such as benzodiazepines, are fairly
nonselective and may cause signiﬁcant adverse effects such as depen-
dence, withdrawal syndrome or muscle relaxation.
Manyplants exert recognizedmedicinal effects on the central nervous
system and are able to act on chronic conditions such as anxiety and
depression that do not respond well to conventional therapeutic treat-
ments (Blanco et al., 2009). Due to the constant need to identify new
treatments for anxiety disorders, aromatherapy has grown in importance
as an area in alternative medicine with proven high efﬁcacy in reducing
stress and improving mood disorders (Bradley et al., 2007a; Steﬂitsch
and Steﬂitsch, 2008).
According to Umezu et al. (2002), although the odor of OEs appears
to exert an active effect, this odor alone is ineffective because of an
õadaptation that occurs in olfactory receptor cells. The same author
has suggested that EOs may possess psychoactive activity, affecting
brain function pharmacologically (Umezu, 1999, 2000; Umezu et al.,
2001).
When inhaled through the nose and olfactory cortex, the odors of
EOs seem to exert a direct effect on the limbic system where anxiety
and emotions are usually generated (Bradley et al., 2007a). This gives
inhalation an advantage over other routes of administration such as,
for example, the oral route, and eliminates the possibility of any
chemical changes to the oil as it passes through the digestive system
(Bradley et al., 2007a).
Linalool, a monoterpene found in high concentrations in the EOs
of various species of aromatic plants, has been used in traditional
medical systems to relieve symptoms and cure a variety of diseases
(Peana et al., 2002). It is a mono-oxygenated monoterpene containing
a chiral center. The anxiolytic activity of this metabolite has been
reported in the literature. Linalool oxide is a di-oxygenatedmonoterpene
containing two chiral centers. The more complex stereochemistry ofFig. 5. Effect of linalool oxide on the transitions number between compartments in
light–dark box test. Evaluation of different concentrations of inhaled linalool and diaz-
epam i.p. in male mice. Data are expressed as mean±SEM. N=8. * pb0.05, ** pb0.01,
*** pb0.001 compared with controls; ANOVA/Bonferroni multiple comparisons test.
Fig. 6. Effect of linalool oxide upon the ability of mice to remain on the bar in rotarod test. Evaluation of different concentrations of inhaled linalool oxide and diazepam i.p. in male
mice. Data are expressed as mean±SEM. N=8, ** pb0.01 compared with control; ANOVA/Bonferroni multiple comparisons test.
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associated with anxiolytic activity. We believe that linalool oxide has a
better pharmacological proﬁle compared to that of linalool. In fact, it
is known that 2,5-substituted tetrahydrofuran subunits are found in
many biologically active natural products and contribute to the phar-
macological action of various natural substances (McLaughlin, 2008;
Bermejo et al., 2005). There is a growing interest in this chemical
group. Therefore, these experimental results with linalool oxide repre-
sent the ﬁrst report of the anxiolytic activity of a representative natural
molecule of the 2,5-substituted tetrahydrofuran group. Investigation of
its mechanism of action should be an objective of future studies.
\In the present study, the effect of linalool oxide was investigated
in mice, being administered by inhalation at concentrations of 0.65%,
1.25%, 2.5% and 5.0%. Results show that the anxiolytic drug proﬁle of
this monoterpene is similar to that of linalool in mice when a 3% con-
centration is inhaled (Linck et al., 2010).
The EPM test is a useful and valid animal model for measuring
anxiety by investigating aspects of physiological and pharmacological
behavior (Martinez et al., 2005; Bessa et al., 2005). This method is
able to reproduce anxiolytic or anxiogenic effects in rodents in
which anxiolytic substances tend to increase the number of entries
into the open arms of the device and the time spent there, while
anxiogenic substances have the opposite effect (Lister, 1987, 1990;
Pellow and File, 1986; Santos et al., 2006; Daza-Losada et al., 2008).
In this study, linalool oxide increased the number of entries into the
open arms of the device (Fig. 1) and the time spent in the open
arms of the maze (Fig. 2), behaviors indicative of anxiolytic activity
and similar to the positive pattern effects expected following the
use of diazepam (Deng et al., 2010). The total number of entries in
the maze is calculated by adding the number of times the animal
goes into the open arms of the device plus the number of times it
goes into the closed arms. The total distance traveled by the animals
is a measure of locomotor activity (Faturi et al., 2010), and the results
showed that linalool oxide increased ambulation in these animals
(Fig. 3). The anxiolytic effects of certain drugs such as benzodiaze-
pines are accompanied by decreased locomotor activity and sedation
(Park et al., 2005). Development of new anxiolytics that do not induce
sedative effects and/or inhibit locomotion would be highly useful
(Park et al., 2005). Since OXL stimulated locomotor activity in this
experiment, it is reasonable to conclude that OXL has a better anxiolytic
proﬁle compared with other drugs.
In order to obtain further knowledge on the possible anxiolytic pro-
ﬁle of linalool oxide, the light/dark box test was also performed. This
test is widely used with rodents as a model for screening anxiolytic
and anxiogenic drugs, based on the innate aversion of rodents to well-
lit areas and the spontaneous exploratory behavior of these animals(Wei et al., 2007). An analogy with anxiety is generated by the conﬂict
between the rodent's desire to explore and its aversion to unknown
spaces and brightly lit areas (Pultrini et al., 2006). The anxiolytic-like
effect of a drug may be reﬂected in an increase in the time spent in
the well-lit compartment and by an increase in the number of times
the animal crosses from one compartment to the other (Bradley et al.,
2007b). The results were consistentwith data in the literature, showing
an increase in the time spent in thebrightly lit compartment (Fig. 4) and
an increase in the number of movements from one compartment to the
other (Fig. 5). In the light/dark test, diazepam also caused an increase in
the exploratory behavior of animals by increasing the time they spent
exploring the well-lit area of the box (Fig. 4) as well as the number of
movements between compartments (Fig. 5), conﬁrming its role as a
positive control of anxiety.
The rotarod test was performed to complement the other experi-
ments and to investigate whether linalool oxide would cause muscle
relaxation in the animals. This test is useful for evaluating the integrity
of motor coordination in animals based on their ability to continue
walking on a rotating bar for a certain period of time (Capasso et al.,
1996). It can be used to detect physical disabilities due to pharma-
cological agents such as muscle relaxants and central nervous system
depressants (Sen and Chaudhuri, 1992; Pultrini et al., 2006). When
the performance of animals treated with a certain drug is investigated
using the rotating bar and is found to be similar to that of the control
group, this suggests that motor coordination has not been impaired
in those animals (Blanco et al., 2009). Linalool oxide inhalation did
not appear to cause muscle relaxation or motor coordination deﬁcit,
since there was no decrease in the time spent on the bar compared to
the control group.
The combined results of this study allow us to conclude that lina-
lool oxide exerts an anxiolytic effect on mice without causing motor
impairment. Together with other studies conducted in this area, this
study may lead to further investigation aimed at discovering new
drugs for the treatment of anxiety disorders.
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